Mon. 1 Apr 2024, 4:28pm ET
Benzinga
Earnings, Earnings Beats, Earnings Misses, News
Tonix Pharmaceuticals (NASDAQ:TNXP) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(1.55) by 44.52 percent. This is a 75.43 percent increase over losses of $(3.50) per share from the same period last year. The company reported quarterly sales of $3.80 million which missed the analyst consensus estimate of $5.75 million by 33.91 percent.